Eledon Pharmaceuticals

NEWS

Pictured: Illustration of gloved hands using tools

Biotech Bay

Eledon’s Antibody Aids First Gene-Edited, Pig-to-Human Kidney Transplant

Tegoprubart, Eledon Pharmaceuticals’ experimental anti-CD40L antibody, was part of the immunosuppressive treatment regimen used following the first-ever transplant of a kidney from a genetically modified pig to a human.

March 22, 2024

4 min read

Tyler Patchen

IN THE PRESS

Press Releases

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

November 12, 2024

9 min read

Press Releases

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

November 7, 2024

1 min read

Press Releases

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

October 29, 2024

4 min read

Press Releases

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

October 29, 2024

9 min read

Business

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

September 11, 2024

1 min read

Press Releases

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

September 5, 2024

5 min read

Press Releases

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

August 15, 2024

6 min read

Press Releases

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection

July 29, 2024

4 min read

Drug Development

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism

July 3, 2024

1 min read

Drug Development

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

June 3, 2024

5 min read

JOBS